Keywords: chemotherapy-related cardiac dysfunction; global longitudinal strain; left ventricular ejection fraction; ACE; angiotensin-converting enzyme; CTRCD; chemotherapy-related cardiac dysfunction; GLS; global longitudinal strain; HF; heart failure; LV; left ve
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: cardio-oncology; cardiotoxicity; echocardiography; 2D; 2-dimensional; ASCO; American Society of Clinical Oncology; ASE; American Society of Echocardiography; CTRCD; cancer therapy-related cardiac dysfunction; EACVI; European Association of Cardiovascula
Keywords: cardio-oncology; cardiotoxicity; imaging; CAD; coronary artery disease; CMR; cardiac magnetic resonance; CTRCD; cancer therapeutics-related cardiac dysfunction; EDV; end-diastolic volume; ERNA; equilibrium radionuclide angiocardiography; ESV; end-systolic
Keywords: Cancer; Cardiotoxicity; Echocardiography; Reliability; Reproducibility; 2D; Two-dimensional; CP; Coverage probability; CTRCD; Cancer therapy-related cardiac dysfunction; DCRI; Duke Clinical Research Institute; ECL; Echocardiography core laboratory; GLS;
Keywords: Cardio-oncology units; Cardiotoxicity; Cancer patients; Cancer survival; Unidades de cardio-oncologÃa; Cardiotoxicidad; Paciente con cáncer; Superviviente al cáncer; CTRCD; cancer therapeutics-related cardiac dysfunction; CV; cardiovascular; CVD; cardi
Keywords: Cardiotoxicity; Chemotherapy; Heart failure; Echocardiography; Cardiotoxicidad; Quimioterapia; Insuficiencia cardiaca; EcocardiografÃa; 2DE; 2-dimensional echocardiography; 3DE; 3-dimensional echocardiography; CMR; cardiac magnetic resonance; CT; compute
Keywords: arginine metabolism; cardio-oncology; cardiotoxicity; doxorubicin; nitrosative stress; trastuzumab; ADMA; asymmetric dimethylarginine; BMI; body mass index; CI; confidence interval; CTRCD; cancer therapeutics-related cardiac dysfunction; IQR; interquart
Keywords: cardio-oncology; cardiotoxicity; echocardiography; mechanics; AUC; area under the receiver-operating characteristic curve; CI; confidence interval; CTRCD; cancer therapeutics-related cardiac dysfunction; Ea; effective arterial elastance; Eessb; end-syst
Keywords: Anthracyclines; Cardiotoxicity; Myocardial strain; Cardiovascular imaging agents/techniques; Echocardiography; AUC; Area under the curve; CMR; Cardiac magnetic resonance imaging; CTRCD; Cancer therapeutics-related cardiac dysfunction; EF; Ejection fract
Keywords: Chemotherapy; Doxorubicin; Trastuzumab; Left ventricular dysfunction; Three-dimensional echocardiography; Early detection; Strain; Biomarkers; ASE; American Society of Echocardiography; BNP; Brain-type natriuretic peptide; CAD; Coronary artery disease; CM
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations
Keywords: Cardio-Oncology; Chemotherapy; Radiotherapy; Cardiotoxicity; Cardio-OncologÃa; Quimioterapia; Radioterapia; Cardiotoxicidad; CTRCD; cancer therapeutics-related cardiac dysfunction; CVDs; cardiovascular diseases; CVR; cardiovascular risk; CVRFs; cardiovas
Summary of the 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Keywords: CVD; cardiovascular disease; HER2; human epidermal growth factor receptor 2; HF; heart failure; T-DM1; trastuzumab, pertuzumab, trastuzumab-emtansine; TKI; lapatinib; LV; left ventricular; ACE; angiotensin-converting enzyme (ACE) inhibitors; VEGF; vascula